Publications

Comparative Antimicrobial Activity and Spectrum of Retapamulin (RE) Against Drug-Resistant Organisms, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Quality Control Guidelines for Testing Retapamulin by CLSI Broth Microdilution and Disk Diffusion Methods, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Assessment of Pathogen Frequency and Resistance (R) Patterns Among Pediatric Patients (PP): Report from the SENTRY Antimicrobial Surveillance Program (2004) on Three Continents, Lead author: Fedler K, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Evaluation of Clinical Outcome among Patients with ESBL-Producing Enterobacteriaceae (ETB) Treated with Cephalosporin (CEPH) Monotherapy, Lead author: Craig WA, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Geographic Antimicrobial Resistance Variability among Bacterial Pathogens Causing Nosocomial Pneumonia in North America (NA): An Eight-Year Analysis from the SENTRY Antimicrobial Surveillance Program, 1997-2004, Lead author: Biedenbach DJ, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Activity of Gemifloxacin Tested against Historical and Contemporary Isolates of Neisseria gonorrhoeae (NG) Including Fluoroquinolone-Resistant Strains (QRNG), Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Contemporary Occurrence of Mobile AmpC-Type ß-Lactamase Resistances (R) in E. coli (EC): Report from the SENTRY Antimicrobial Surveillance Program (USA, 2004), Lead author: Jones RN, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Antimicrobial Activity of Broad Spectrum Parenteral Cephalosporins Tested against Bacterial Isolates from Pediatric Patients: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Sader HS, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Geographic Occurrence and Resistance Patterns among Pathogens Isolated from Skin and Soft Tissue Infections (SSTI): A Report from the SENTRY Antimicrobial Surveillance Program (2004), Lead author: Fritsche TR, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Antimicrobial Activity of Alternative Broad-Spectrum Agents against Imipenem-Non-Susceptible Gram-Negative Bacilli: Report from the USA MYSTIC Programme, 1999 – 2004, Lead author: Fritsche TR, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Update on Daptomycin Antimicrobial Activity When Tested against Clinical Strains from North American Medical Centers (2004), Lead author: Sader HS, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Susceptibility Patterns for Amoxicillin/Clavulanate Tests Simulating Licensed Formulations and Pharmacokinetic Relationships: Does the 2:1 Ratio MIC Accurately Reflect Activity against Beta-Lactamase Producing H. influenzae and M. catarrhalis, Lead author: Fritsche TR, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Re-Evaluation of the Bactericidal Activities and the Correlation between Disk Diffusion and MIC Methods for Testing Daptomycin and Vancomycin against S. aureus with Decreased Susceptibility (S) to Gylcopeptides, Lead author: Sader HS, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Antimicrobial Activities of Cefepime and Piperacillin/Tazobactam against E. coli and Klebsiella spp. with ESBL-Phenotype Collected Worldwide, Lead author: Sader HS, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Potential Role for Triple Antibiotic Ointment (TAO) Against Mupirocin-Resistant Staphylococci: A USA and Australian Clinical Isolate Sample, Lead author: Jones RN, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Daptomycin Resistance and Vancomycin Intermediate S. aureus in a Patient with Prolonged Antibiotic Therapy, Lead author: Mariani P, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Global Assessment of the Polymyxin B Activity Tested against 55,151 Clinical Strains of Gram-Negative Bacilli: Report from the SENTRY Antimicrobial Surveillance Program (2001-2004), Lead author: Jones RN, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Spectrum and Potency of Dalbavancin Tested against 3,322 Gram-Positive Cocci Isolated in the USA Surveillance Program (2004), Lead author: Jones RN, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Activity of Tigecycline (TIG) Tested Against Non-Fermentative Gram-Negative Bacilli (NFB), Including Imipenem-Non-Susceptible (IMP-NS) Strains, and ESBL-producing Enterobacteriaceae (ENT), Lead author: Fritsche TR, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Persistent Occurrence of Clonally Related Multi-Drug Resistant Acinetobacter Spp. Isolates Within the MYSTIC Programme Medical Centers (USA, 1999 – 2004), Lead author: Rhomberg PR, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Potential Options for Parental Therapy of Community-Acquired Infections Caused by Levofloxacin-Resistant Streptococcus pneumoniae: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Fritsche TR, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Comparative Antimicrobial Spectrum and Potency of Meropenem Tested Against Enterobacteriaceae and Non-Fermentative Gram-Negative Bacilli: Report from the 2004 MYSTIC Program (USA), Lead author: Jones RN, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Comprehensive In Vitro Evaluation of Cefepime Combined with Aztreonam or Ampicilin/Sulbactam Against Multi-Drug Resistant Pseudomonas aeruginosa and Acinetobacter spp., Lead author: Sader HS, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Antimicrobial Activity of the Novel Peptide Deformylase Inhibitor LBM415 (NVP PDF-713) Against an International Collection of Respiratory Tract, Skin and Soft Tissue Pathogens (2004), Lead author: Watters A, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Influence of Errors Caused by Automated Systems in the Antimicrobial Susceptibility Rates of Pseudomonas aeruginosa against Selected Beta-Lactam Antimicrobials, Lead author: Sader HS, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

In Vitro Evaluation of Dalbavancin in Combination with Other Classes of Antimicrobial Agents, Lead author: Johnson DM, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Reproducibility of Daptomycin MIC Results Using Dry-Form Commercial Trays with Supplemental Calcium Content, Lead author: Rhomberg PR, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Evaluation of Bactericidal Activity of Daptomycin and Vancomycin Tested Against Staphylococcus aureus (VISA, hVISA, and wild-types), Lead author: Sader HS, presented at 8th annual International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections, May 22 – 24, 2005, Charleston, South Carolina

Daptomycin Tested Against 915 Bloodstream Isolates of Viridans Group Streptococci (Eight Species) and Streptococcus Bovis, Lead author: Streit J, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

In Vitro Evaluation of the Peptide Deformylase Inhibitor LBM415 in Combination with Aztreonam to Determine the Synergistic Potential Against Gram-positive and Gram-negative Pathogens, Lead author: Biedenbach DJ, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Antimicrobial Activity of LBM415 (NVP PDF-713) Against a Recent (2003) International Collection of Gram-positive and Respiratory Tract Pathogens, Lead author: Watters A, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Antimicrobial Activity of Daptomycin Tested Against Gram-positive Strains Collected from European Medical Centres in 2004, Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

In Vitro Activity of Garenoxacin, a Novel Des-F(6)-quinolone, and Other Orally Administered Antimicrobials Tested Against 50,217 Enterobacteriaceae Collected Worldwide by the SENTRY Antimicrobial Surveillance Program (1999-2003), Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Potency of Garenoxacin, a New Des-F(6)-quinolone, Tested Against Community-acquired Respiratory Tract Infection Pathogens Worldwide (29,837 Strains): Report from the SENTRY Antimicrobial Surveillance Program (1999-2003), Lead author: Jones RN, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Garenoxacin Activity Against Isolates from Patients Hospitalised with Community-acquired Pneumonia (Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis; 3,087 strains): Report from the SENTRY Antimicrobial Surveillance Program (1999-2003), Lead author: Jones RN, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Potency and Spectrum of Garenoxacin Tested Against an International Collection of Skin and Soft Tissue Infection Pathogens: Report from the SENTRY Antimicrobial Surveillance Program (1999-2003), Lead author: Fritsche TR, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Antimicrobial Susceptibility of 5,859 non-Enterobacteriaceae Gram-negative Organisms Other than Pseudomonas aeruginosa Tested Against the Novel Des-F(6)-quinolone, Garenoxaxin (SENTRY Antimicrobial Surveillance Program, 1999-2003), Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Delayed Resistance Selection for Doripenem when Passaging P. aeruginosa Isolates with an Aminoglycoside, Lead author: Biedenbach DJ, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Linezolid Susceptibility Testing Results in Europe: Report from the Worldwide ZAAPS Program (2003), Lead author: Ross JE, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Significant Increases in the Rate of Fluoroquinolone Resistance Among Gram-negative Bacilli: Six-year (1999-2004) Report from the USA MYSTIC Programme, Lead author: Rhomberg PR, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Accuracy of Three Automated Systems for Susceptibility Testing Selected Gram-negative Bacilli Against Five Broad-spectrum Beta-Lactam Agents, Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Susceptiblity Patterns for Amoxicillin/clavulanate Tests Mimicking Newly Indicated Formulations and Pharmacokinetic Relationships: Does 2:1 Ratio MIC Accurately Reflect Activity Against Beta-Lactamase-Producing H. influenzae and M. catarrhalis, Lead author: Jones RN, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Diverse Transposons Are Responsible for the Dissemination of Japanese Metallo-beta-lactamase Alleles: Report from the SENTRY Surveillance Programme, Lead author: Toleman MA, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Genetic Characterisation of the IMP-1 Metallo-beta-lactamase Gene in Enterobacter cloacae Strains from Turkey, Lead author: Toleman MA, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

In Vitro Activity of Beta-Lactam Antimicrobial Agent Combinations with Aztreonam When Testing Metallo-Beta-Lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp., Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Transfer and Carriage of Naturally Occurring Pseudomonas aeruginosa Plasmids Harbouring Metallo-beta-lactamase to Enterobacteriaceae Strains, Lead author: Castanheira M, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Antimicrobial Activity of Tigecycline Tested Against Bacterial Pathogens from Intensive Care Units, Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Potency and Spectrum of Tigecycline Tested Against an International Collection (1999-2003) of Bacterial Pathogens Producing Skin and Soft Tissue Infections, Lead author: Fritsche TR, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Tigecycline Activity Tested Against 22,950 Bloodstream Infection Isolates Worldwide, Lead author: Jones RN, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

In Vitro Activity of New Compounds Tested Against Multi-Drug Resistant S. aureus Isolated in Latin American Medical Centers (LAMCs), Lead author: Gales AC, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark